Clinical Trial Update: Cera™ VSD Occluder Post Market Clinical Follow-up

View source ↗

Summary

This clinical trial update reports the post-market clinical follow-up for the Cera VSD Occluder and states that the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Septal Defect

Drugs mentioned

• Cera VSD Occluder (Ventricular septal defect occluder device)

Snippet

Sponsor: Cardiac Children's Foundation Taiwan | Conditions: Ventricular Septal Defect | Status: COMPLETED